Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
    • Internet & Telecom
  • Toggle search form
  • [Research] Samsung Electronics (005930) – Hyundai Motor Securities | Memory Supply Bottlenecks · LTA Defensiveness · Pure Memory Valuation / 2026-06-29 Research
  • [Research] Samsung Biologics (207940) – Daishin Securities | Peptide Market Entry · Global Footprint Expansion · Modality Diversification / 2026-07-21 Research
  • [Research] Samsung Electronics (005930) – Mirae Asset Securities | Shareholder Return · FCF Expansion · Valuation Discount / 2026-07-29 Research
  • [Research] Samsung Electronics (005930) – Hana Securities | Memory ASP Surges · HBM Competitiveness Recovery · Expanding Shareholder Returns / 2026-01-30 Research
  • [Research] Hanwha Ocean (042660) – Yuanta | Merchant Mix Improvement · CPSP Project Value · MASGA Catalysts / 2026-07-06 Shipbuilding
  • [Research] SK hynix (000660 / SKHY) – Shinhan | Supply Constraints · Memory Pricing · LTA / 2026-04-24 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Agentic AI · Server CPU · LPDDR / 2026-04-28 Research
  • [Research] Hanwha Ocean (042660) – Daishin | Early Offshore Revenue · Naval Defense Pipeline · Excessive Discount / 2026-07-09 Research

[Research] KEPCO (015760 / KEP) – Hana Securities | Industrial Tariff Cut Pressure · Subsidiary Cost Risks · Nuclear Output Normalization / 2026-02-27

Posted on 2월 27, 20268월 25, 2026 By ksb220805@gmail.com

Market: KOSPI (015760)

Brokerage : Hana Securities

Analyst : Jae-seon Yoo (RA: Woo-kyu Sung)

Investment Rating : BUY (Maintained)

Target Price : KRW 73,000 (Upgraded)

Core Momentum : While 4Q earnings missed consensus and risks surrounding industrial tariff cuts and subsidiary overseas project costs linger, favorable settlement adjustments and 2H nuclear power ramp-ups support an upgraded target price.

📊 1. [Valuation & Key Financial Metrics]

  • Rating & Target Price: BUY (Maintained), 12-Month Target Price raised by 12.3% to KRW 73,000 (applying a Target P/B of 0.8x to 2026E BPS).
  • Valuation Multiples: 2026F P/E 4.61x (Consensus 4.6x), P/B 0.73x (Consensus 0.7x).
  • Financial Estimates:
    • 2024A: Revenue KRW 93.40 Trillion, Operating Profit KRW 8.36 Trillion, Net Profit KRW 3.49 Trillion, EPS KRW 5,439, ROE 9.22%, P/E 3.69x, P/B 0.32x, DPS KRW 213.
    • 2025P: Revenue KRW 97.43 Trillion, Operating Profit KRW 13.52 Trillion, Net Profit KRW 8.62 Trillion, EPS KRW 13,423, ROE 19.61%, P/E 3.52x, P/B 0.63x, DPS KRW 1,540 (Dividend payout ratio set at 13.7%, down 2.7%p YoY).
    • 2026F: Revenue KRW 97.77 Trillion, Operating Profit KRW 14.44 Trillion, Net Profit KRW 8.82 Trillion, EPS KRW 13,731, ROE 17.00%, P/E 4.61x, P/B 0.73x, DPS KRW 1,790.

🚀 2. [Market Opportunities & Business Outlook]

  • 4Q25 Earnings Review:
    • Revenue reached KRW 23.7 Trillion (+0.7% YoY) and Operating Profit recorded KRW 2.0 Trillion (-18.0% YoY), missing market consensus.
    • Overall power sales volume fell 1.4% YoY due to weak industrial demand, while ASP rose 2.4% YoY; past tariff hike effects fully expired with this quarter.
    • Nuclear utilization declined to 75.1% (-11.7%p YoY), which increased coal generation; however, reduced LNG generation led to a 5.8% YoY decline in fuel costs to KRW 4.6 Trillion.
    • Power purchase costs decreased to KRW 7.4 Trillion (-5.0% YoY) helped by lower SMPs despite a lower baseload output share.
    • Operating expenses saw a sharp rise in other expenses, driven by concentrated recognition of subsidiary overseas project expenses and provisions.
  • Cost Variables & Earnings Drivers:
    • Subsidiary overseas project costs, rising since 1Q25, pose ongoing potential liability recognition risks until project completion in 2029.
    • Downward movement in SMP is likely limited beyond 2Q26.
    • Full-year 2026 nuclear utilization is projected to follow a low-first-half, high-second-half trajectory due to scheduled maintenance.
  • Policy & Regulatory Catalysts:
    • Favorable settlement coefficient adjustments for KEPCO’s parent entity provide structural capital expansion support ahead of bond issuance limit constraints.
    • Discussions underway for seasonal and time-of-use tariff adjustments for industrial users (likely structured as tariff reduction benefits to prevent industrial load loss).
    • Near-term visibility on overseas nuclear exports remains low outside of Southeast Asia, though mid-to-long term project pipelines remain relevant.

📝 Editor’s Comment (Perspective)

The analyst views KEPCO as a regulated utility navigating the expiration of historical tariff hike benefits alongside persistent risks from subsidiary overseas project costs and potential industrial tariff cuts, but one reinforcing its financial baseline through favorable parent-level settlement adjustments. The core perspective prioritizes structural equity defense via regulatory mechanisms and generation mix normalization from 2H nuclear restarts over speculative near-term overseas contract catalysts or expectations of additional tariff hikes.

To verify whether this investment thesis unfolds as anticipated, key tracking points include the magnitude of additional provisions and contingency expenses recognized from subsidiary overseas projects through 2029, the finalized framework of seasonal and time-of-use industrial tariffs and its impact on average selling prices, and the recovery rate of nuclear utilization in 2H26. These developments can be monitored through KEPCO’s quarterly financial disclosures, notes on contingent liabilities in periodic reports, KPX power market data, and official MOTIE regulatory releases.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Energy

글 탐색

Previous Post: [Research] SK hynix (000660 / SKHY) – SK Securities | AI Memory · NAND Tiering · Earnings Re-rating / 2026-02-24
Next Post: [Research] KEPCO (015760 / KEP) – Daishin Securities | Overseas Nuclear Expansion · Nuclear Utilization Recovery · 2026 Earnings Growth / 2026-02-27

Related Posts

  • [Research] Samsung Electronics (005930) – SK Securities | AI Memory Expansion · Complex Supply Constraints · Earnings Power Redefinition / 2026-02-24 Research
  • [Research] LIG D&A (079550) – SK Securities | Modern Warfare Leader · Limited Global CapEx · Multiple Re-rating / 2026-04-07 Research
  • [Research] Samsung Electronics (005930) – Kiwoom Securities | Strong 1Q26 Outlook · Full-Year Profit Forecast at KRW 172T · HBM Surge / 2026-01-30 Research
  • [Research] Samsung Electronics (005930) – Hana Securities | Memory ASP Upgrades · Full-Year Earnings Upward Revision · FCF-Driven Shareholder Returns / 2026-03-13 Research
  • [Research] LigaChem Biosciences (141080) – Eugene Investment & Securities | Pipeline Clinical Progression · Licensing Revenue · Earnings Turnaround / 2025-02-17 Research
  • [Research] Samsung Biologics (207940) – iM Securities | Spin-off Valuation Re-rating · Biosecure Act Inflows · Plant 6 Groundbreaking / 2026-01-09 Research
  • [Research] Samsung Biologics (207940) – IBK Securities | Plant 5 PPQ Revenue · US Site Consolidation · Guidance Revision Potential / 2026-04-23 Research
  • [Research] Hanwha Ocean (042660) – Shinhan | Merchant Profit Level-Up · Special Ship Order Variables · Balanced Portfolio / 2026-07-28 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | ESS & BBU Growth · Profit Turnaround · Core Earnings Sustainability / 2026-07-31 Research
  • [Research] Samsung Electronics (005930) – Daishin Securities | Memory Earnings Power · HBM Pricing · Share Buyback / 2026-07-07 Research
  • [Research] Samsung Biologics (207940) – Kiwoom Securities | Plant 5 & Rockville Ramp-up · Guidance Upside · 4Q Earnings Concentration / 2026-07-24 Research
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | MLCC Price Cycle · Customer Prepayments · Server Demand / 2026-08-11 Research
  • [Research] SK hynix (000660 / SKHY) – Hanwha | LTA · HBM · Earnings Sustainability / 2026-04-24 Research
  • [Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme